Sitara Peroxide Limited (PSX:SPL)
51.12
+1.85 (3.75%)
At close: Oct 19, 2026
Sitara Peroxide Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3.88 | 5.66 | 11.38 | 9.14 | 1.82 |
Cash & Short-Term Investments | 3.88 | 5.66 | 11.38 | 9.14 | 1.82 |
Cash Growth | -31.52% | -50.26% | 24.55% | 403.15% | -94.01% |
Accounts Receivable | - | - | 64.78 | 127.39 | 215.24 |
Other Receivables | 75.93 | 75.4 | 94.95 | 131.69 | 182.32 |
Receivables | 75.93 | 75.4 | 159.74 | 259.09 | 397.56 |
Inventory | 255.98 | 338.48 | 338.48 | 342.41 | 389.05 |
Prepaid Expenses | - | - | - | - | 0.33 |
Other Current Assets | 20.05 | 56.11 | 23.3 | 105.87 | 200.68 |
Total Current Assets | 355.83 | 475.65 | 532.89 | 716.51 | 989.44 |
Property, Plant & Equipment | 1,969 | 2,146 | 2,369 | 2,558 | 2,789 |
Other Long-Term Assets | 180.37 | 162.37 | 162.37 | 162.37 | 127.44 |
Total Assets | 2,505 | 2,784 | 3,064 | 3,437 | 3,906 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 668.04 | 411.19 | 370.88 | 306.97 | 233.84 |
Accrued Expenses | 27.4 | 492.36 | 475.48 | 401.57 | 355.61 |
Short-Term Debt | 422.97 | 387.51 | 387.88 | 345.47 | 154.18 |
Current Portion of Long-Term Debt | 12 | 101.74 | 126.74 | 308.49 | 236.71 |
Current Income Taxes Payable | 2.4 | - | 0.2 | 12.64 | 23.01 |
Current Unearned Revenue | 114.69 | 114.69 | 114.69 | 120.07 | 178.84 |
Other Current Liabilities | - | 30.93 | 30.92 | 31.07 | 24.55 |
Total Current Liabilities | 1,247 | 1,538 | 1,507 | 1,526 | 1,207 |
Long-Term Debt | - | - | - | - | 17.44 |
Pension & Post-Retirement Benefits | - | - | - | 49.63 | 37.13 |
Long-Term Deferred Tax Liabilities | 121.2 | 256.96 | 345.79 | 479.8 | 508.85 |
Other Long-Term Liabilities | - | - | - | -0 | - |
Total Liabilities | 1,369 | 1,795 | 1,853 | 2,056 | 1,770 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 551 | 551 | 551 | 551 | 551 |
Retained Earnings | -591.39 | -841.72 | -720.67 | -639.8 | 140.65 |
Comprehensive Income & Other | 1,177 | 1,280 | 1,381 | 1,470 | 1,444 |
Shareholders' Equity | 1,137 | 989.06 | 1,212 | 1,381 | 2,136 |
Total Liabilities & Equity | 2,505 | 2,784 | 3,064 | 3,437 | 3,906 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 434.97 | 489.25 | 514.62 | 653.96 | 408.33 |
Net Cash (Debt) | -431.09 | -483.59 | -503.24 | -644.83 | -406.51 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -7.83 | -8.78 | -9.13 | -11.70 | -7.38 |
Filing Date Shares Outstanding | 54.79 | 55.1 | 55.1 | 55.1 | 55.1 |
Total Common Shares Outstanding | 54.79 | 55.1 | 55.1 | 55.1 | 55.1 |
Working Capital | -891.67 | -1,063 | -973.9 | -809.78 | -217.3 |
Book Value Per Share | 20.74 | 17.95 | 21.99 | 25.06 | 38.76 |
Tangible Book Value | 1,137 | 989.06 | 1,212 | 1,381 | 2,136 |
Tangible Book Value Per Share | 20.74 | 17.95 | 21.99 | 25.06 | 38.76 |
Land | - | 308.28 | 308.28 | 308.28 | 308.28 |
Buildings | - | 253.33 | 253.33 | 253.33 | 253.33 |
Machinery | - | 2,522 | 2,605 | 2,615 | 2,683 |